Back
ESC2025 Premium Access

Tachycardiomyopathy is associated with metabolic changes that predict LVEF recovery - results from the EMPATHY study

Session: Atrial fibrillation and heart failure: a deadly combination
Topic: Pathophysiology and Mechanisms
Speaker: Doctor D. Heinzmann (Tuebingen, DE)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor David Heinzmann

Eberhard-Karls University of Tubingen, Tuebingen (Germany)
0 follower

4 more presentations in this session

Prognostic implications of atrial fibrillation in young patients without overt heart disease - an early marker of future cardiomyopathy ?

Speaker: Doctor P. Rasmussen (Copenhagen, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Integrating pre- and post-ablation B-type natriuretic peptide to identify high-risk population for long-term adverse events and arrhythmic recurrence in persistent atrial fibrillation

Speaker: Doctor S. Hashimoto (Ube, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

ECG changes predict new-onset heart failure in patients with atrial fibrillation.

Speaker: Doctor C. Binding (Copenhagen, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Care and outcomes of atrial fibrillation in potentially vulnerable populations: A 20-year perspective using real-world data

Speaker: Doctor N. Nouhravesh (Durham, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Atrial fibrillation and heart failure: a deadly combination

Speakers: Doctor D. Heinzmann, Doctor P. Rasmussen, Doctor S. Hashimoto, Doctor C. Binding, Doctor N. Nouhravesh
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources